China Universal Asset Management Co., Ltd. Janux Therapeutics, Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Janux Therapeutics, Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 11,855 shares of JANX stock, worth $293,529. This represents 0.03% of its overall portfolio holdings.
Number of Shares
11,855
Previous 11,128
6.53%
Holding current value
$293,529
Previous $595,000
46.22%
% of portfolio
0.03%
Previous 0.06%
Shares
8 transactions
Others Institutions Holding JANX
# of Institutions
193Shares Held
57.3MCall Options Held
626KPut Options Held
155K-
Ra Capital Management, L.P. Boston, MA11.2MShares$277 Million6.27% of portfolio
-
Janus Henderson Group PLC London, X04.6MShares$114 Million0.07% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.65MShares$90.5 Million0.19% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.33MShares$82.4 Million4.61% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$58 Million0.0% of portfolio
About Janux Therapeutics, Inc.
- Ticker JANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,663,000
- Market Cap $1.03B
- Description
- Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth ...